Enhancing GD2-CAR NKT anti-tumor efficacy against neuroblastoma by targeting BLIMP1
Enhancing GD2-CAR NKT anti-tumor efficacy against neuroblastoma by targeting BLIMP1
Dr. Gengwen Tian, M.D., Ph.D. – Baylor College of Medicine, Houston TX
Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Dr. John Prensner, M.D., Ph.D. – The Regents of the University of Michigan, Ann Arbor, MI
Targeting ALT-Associated Vulnerabilities in Pediatric High-Grade Glioma
Targeting ALT-Associated Vulnerabilities in Pediatric High-Grade Glioma
Dr. Jihye Paik, Ph.D. – Weill Medical College of Cornell University, New York, NY
Development of a Measure of Social Connectedness for Survivors of Pediatric Brain Tumors
Development of a Measure of Social Connectedness for Survivors of Pediatric Brain Tumors
Dr. Matthew Hocking, Ph.D. – The Children's Hospital of Philadelphia, Philadelphia, PA
GLUL as a novel therapeutic target in pediatric T-ALL
GLUL as a novel therapeutic target in pediatric T-ALL
Dr. Daniel Herranz, Ph.D. – Rutgers Biomedical and Health Sciences (Rutgers Health), New Brunswick, NJ
Dissecting CBFA2T3-GLIS2 Fusion-Driven Leukemogenesis and Therapeutic Resistance
Dissecting CBFA2T3-GLIS2 Fusion-Driven Leukemogenesis and Therapeutic Resistance
Dr. Brandon Hadland, M.D. – Fred Hutchinson Cancer Center, Seattle, WA
Tumor-specific PROTAC development as a new therapeutic approach for osteosarcoma
Tumor-specific PROTAC development as a new therapeutic approach for osteosarcoma
Dr. Gunda Georg, Ph.D. – Regents of the University of Minnesota - Twin Cities, Minneapolis, MN
Dissecting Ewing Sarcoma On-Chip for Better Therapeutics
Dissecting Ewing Sarcoma On-Chip for Better Therapeutics
Dr. Yuan Gao, Ph.D. – Case Western Reserve University - School of Medicine, Cleveland, OH
Mapping Mitochondrial-localized mRNA Translational Rewiring in Radiation-resistant Pediatric DIPG
Mapping Mitochondrial-localized mRNA Translational Rewiring in Radiation-resistant Pediatric DIPG
Dr. Furqan Fazal, Ph.D. – Baylor College of Medicine, Houston, TX
Linking the Gut Microbiome to Chemotherapy Toxicity in Pediatric ALL
Linking the Gut Microbiome to Chemotherapy Toxicity in Pediatric ALL
Dr. Eran Elinav, M.D., Ph.D. – Weizmann Institute of Science, Israel
Development and Validation of Patient-Reported Outcome Measures for Pediatric Cancer Surgery
Development and Validation of Patient-Reported Outcome Measures for Pediatric Cancer Surgery
Dr. Roshni Dasgupta, M.D. – Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Deciphering mutually exclusive T-ALL and neurodevelopmental mutations in the ARD domain of the ZMIZ1 coactivator
Deciphering mutually exclusive T-ALL and neurodevelopmental mutations in the ARD domain of the ZMIZ1 coactivator
Dr. Mark Chiang, M.D., Ph.D. – The Regents of the University of Michigan, Ann Arbor, MI
Precision Epigenetic Therapies for Pediatric Burkitt Lymphoma
Precision Epigenetic Therapies for Pediatric Burkitt Lymphoma
Dr. Darko Barisic, Ph.D. – Weill Medical College of Cornell University, New York, NY
Identify Genetic Drivers Metastasis Using an Established Zebrafish Model of High-Risk Neuroblastoma
Identify Genetic Drivers Metastasis Using an Established Zebrafish Model of High-Risk Neuroblastoma
Dr. Nicole Anderson, Ph.D. – University of Mississippi Medical Center, Jackson, MS
In a FLASH: reducing toxicity and enhancing cure for pediatric brain tumors
In a FLASH: reducing toxicity and enhancing cure for pediatric brain tumors
Dr. Sahaja Acharya, M.D. – Johns Hopkins University School of Medicine, Baltimore, MD
![Clinical [89Zr]Dinutuximab PET imaging to determine GD2 expression in neuroblastoma patients with PET](https://images.squarespace-cdn.com/content/v1/60b687d7c75a235d721c70d5/8c900f9c-6d15-45da-8393-2b43144a123d/Princess+Maxima.png)
Clinical [89Zr]Dinutuximab PET imaging to determine GD2 expression in neuroblastoma patients with PET
Clinical [89Zr]Dinutuximab PET imaging to determine GD2 expression in neuroblastoma patients with PET
Dr. Max M. van Noesel, MD. PhD, MSc; – Princess Máxima Center, Utrecht, The Netherlands
Comprehensive molecular profiling of pediatric adrenal tumors
Comprehensive molecular profiling of pediatric adrenal tumors
Dr. Ronald de Krijger – Princess Máxima Center, Utrecht, The Netherlands
Pulmonary complications in children with solid tumors
Pulmonary complications in children with solid tumors
Dr. S.M.P.J. Prevaes; Dr. M. van Grotel – Princess Máxima Center, Utrecht, The Netherlands
Androgen activity in the normal male embryonic hindbrain drives lethal PFA ependymoma
Androgen activity in the normal male embryonic hindbrain drives lethal PFA ependymoma
Dr. Jiao Zhang, Ph.D. – Baylor College of Medicine, Houston TX